Edwards Lifesciences (EW) Tops Q3 EPS by 1c; offers guidance
Tweet
Share
E-mail
Get Alerts EW Hot Sheet
Price: $94.82 -0.38%
EPS Growth %: +10.4%
Financial Fact:
Selling, general and administrative expenses: 229.6M
Today's EPS Names:
EPAC, SAR, KRUS, More
EPS Growth %: +10.4%
Financial Fact:
Selling, general and administrative expenses: 229.6M
Today's EPS Names:
EPAC, SAR, KRUS, More
Join SI Premium – FREE
Edwards Lifesciences (NYSE: EW) reported Q3 EPS of $0.67, $0.01 better than the analyst estimate of $0.66. Revenue for the quarter came in at $1.35 billion versus the consensus estimate of $1.57 billion.
GUIDANCE:
Edwards Lifesciences sees Q4 2024 EPS of $0.53-$0.57, versus the consensus of $0.60. Edwards Lifesciences sees Q4 2024 revenue of $1.33-1.39 billion, versus the consensus of $1.396 billion.
For earnings history and earnings-related data on Edwards Lifesciences (EW) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SpaceX plans to launch new AI model with Cursor - The Information
- Freedom Broker Starts Holley (HLLY) at Buy
- UBS Starts Regis Healthcare Ltd. (REG:AU) at Neutral
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
